Results 171 to 180 of about 54,076 (279)

EMA/HMA - HMA-EMA joint Big Data Steering Group: publication of the updated 2023-2025 workplan

open access: yes
The HMA-EMA joint Big Data Steering Group updated and published its 2023-2025 workplan. This document introduces each topic and outlines key deliverables. The plan was informed by stakeholder and expert consultation. The document is structured in line with the key recommendations of the Big Data Task Force (see Annex I).
openaire   +1 more source

Phytochemical Analysis of Veratrum Alkaloids in Medicinal Veratrum Globules Using High‐Performance Liquid Chromatography Coupled With Tandem Mass Spectrometry

open access: yesBiomedical Chromatography, Volume 40, Issue 3, March 2026.
ABSTRACT Veratrum L. species have been used in traditional medicine for centuries due to their bioactive properties, yet they also contain toxic steroid alkaloids that pose potential health risks when present in herbal preparations. Reliable analytical approaches are therefore essential to ensure product safety, protect consumer health and assess ...
Julia Siegle, Jörg Pietsch
wiley   +1 more source

Drivers of clinical resistance to venetoclax and hypomethylating agents in acute myeloid leukemia and strategies for improving efficacy. [PDF]

open access: yesHemasphere
Vänttinen I   +17 more
europepmc   +1 more source

EMA/HMA – List of metadata for the HMA-EMA Catalogues of realworld data sources and studies

open access: yes
The EMA recently published a List of metadata for the HMA-EMA Catalogues of realworld data sources and studies. In line with the Big Data Steering Group workplan and the European medicines agencies network Strategy to 2025 action on data discoverability, and through consultation with its stakeholders, EMA produced a list of metadata for describing real-
openaire   +2 more sources

Transcatheter Left Ventricular Restoration in Ischemic Heart Failure and Dilated Cardiomyopathy

open access: yesCatheterization and Cardiovascular Interventions, Volume 107, Issue 4, Page 898-908, March 1, 2026.
ABSTRACT Ischemic heart disease is the leading global cause of death and frequently progresses to ischemic heart failure (IHF) after myocardial infarction through adverse left ventricular (LV)remodeling. Surgical LV restoration improves ventricular geometry and function but is limited by invasiveness and inconsistent outcomes.
Muhammad Mohid Haroon   +19 more
wiley   +1 more source

Adult Survival in SMA Type 1: A 23‐Year Journey With Home Ventilation and Multidisciplinary Support

open access: yesClinical Case Reports, Volume 14, Issue 3, March 2026.
Diffuse brain atrophy and calvarial hyperostosis in a long‐term survivor of very early onset SMA type 1. ABSTRACT Spinal muscular atrophy (SMA) type 1 is a severe autosomal recessive neuromuscular disorder caused by loss‐of‐function variants in the SMN1 gene, typically leading to death within the first two years without intervention. Long‐term survival
Antonio E. Camelo‐Filho   +4 more
wiley   +1 more source

Home - About - Disclaimer - Privacy